Case T-278/25 R: Order of the President of the General Court of 2 July 2025 – Duchenne Research & Advocacy v Commission (Interim relief – Medicinal products for human use – Refusal to renew the conditional marketing authorisation for Translarna – ataluren – Application for suspension of operation of a measure – Application for interim measures – Failure to comply with procedural requirements – Inadmissibility)